Less than six months after Nasdaq debut, Malaysia’s Alps Group pivots to bridge biotech access gap April 20, 2026
Alps Group Appoints Former Ernst & Young Partner to Board of Directors, Strengthening Governance and Capital Markets Oversight April 17, 2026
Alps Group Inc Publishes Clinical Safety, Tolerability and Effectiveness Data Supporting Advancement of Its Autologous NK Cell February 24, 2026
